NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candid...

Full description

Bibliographic Details
Main Authors: Remy Thomas, Ghaneya Al-Khadairi, Jessica Roelands, Wouter Hendrickx, Said Dermime, Davide Bedognetti, Julie Decock
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Immunology
Subjects:
cancer-testis antigen
NY-ESO-1
adoptive T cell therapy
vaccine
immune checkpoint
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2018.00947/full

Internet

http://journal.frontiersin.org/article/10.3389/fimmu.2018.00947/full

Similar Items